C07D 307/84
Carbon atoms having three bonds to hetero atoms with at the most
Official title: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
C07D307/84 (Carbon atoms having three bonds to hetero atoms with at the most) appears on 511 US grants and 451 published applications in this corpus.
Search patents in C07D- Granted patents
- 511
- Published applications
- 451
- Assignees
- 295
- Inventors
- 1,782
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 5 | 0 |
| 1980 | 10 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 8 | 0 |
| 1984 | 9 | 0 |
| 1985 | 7 | 0 |
| 1986 | 5 | 0 |
| 1987 | 8 | 0 |
| 1988 | 2 | 0 |
| 1989 | 9 | 0 |
| 1990 | 12 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 18 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 10 | 0 |
| 1997 | 14 | 0 |
| 1998 | 11 | 0 |
| 1999 | 9 | 0 |
| 2000 | 8 | 0 |
| 2001 | 9 | 0 |
| 2002 | 19 | 14 |
| 2003 | 14 | 18 |
| 2004 | 9 | 24 |
| 2005 | 7 | 30 |
| 2006 | 14 | 26 |
| 2007 | 13 | 23 |
| 2008 | 14 | 25 |
| 2009 | 23 | 23 |
| 2010 | 16 | 28 |
| 2011 | 16 | 19 |
| 2012 | 18 | 22 |
| 2013 | 14 | 20 |
| 2014 | 21 | 22 |
| 2015 | 18 | 20 |
| 2016 | 15 | 10 |
| 2017 | 10 | 17 |
| 2018 | 16 | 20 |
| 2019 | 12 | 6 |
| 2020 | 8 | 13 |
| 2021 | 11 | 14 |
| 2022 | 7 | 7 |
| 2023 | 3 | 13 |
| 2024 | 7 | 19 |
| 2025 | 7 | 11 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Anthelmintic aza-benzothiophene and aza-benzofuran compounds24 Feb 2026US 12,559,503 B2
- BCKDK inhibitors and/or degraders11 Nov 2025US 12,466,803 B2Pfizer Inc.
- Heterocycle derivatives for treating TRPM3 mediated disorders2 Sep 2025US 12,404,266 B2Katholieke Universiteit Leuven
- Heteroaromatic acetamide derivative, and preparation and use thereof19 Aug 2025US 12,391,660 B2Hangzhou Westan Pharmaceutical Technology Co., Ltd
- Acyl sulfonamides for treating cancer15 Jul 2025US 12,357,603 B2Bayer Aktiengesellschaft
- Anthelmintic aza-benzothiophene and aza-benzofuran compounds8 Oct 2026US 2026/0308170 A1Boehringer Ingelheim Vetmedica GmbH
- Ligand-enabled scalable c-h hydroxylation of benzoic and phenylacetic acids at room temperature2 Apr 2026US 2026/0092029 A1The Scripps Research Institute
- Heterocycle derivatives for treating trpm3 mediated disorders12 Mar 2026US 2026/0070896 A1Katholieke Universiteit Leuven
- Sulfonyl derivatives as ccr6 inhibitors12 Mar 2026US 2026/0070902 A1Hoffmann-La Roche Inc.
- Novel heterocycles as spla2-x inhibitors5 Feb 2026US 2026/0034111 A1Cayman Chemical Company, Incorporated
Most cited
By later US patents
- Modulators of ATP-binding cassette transporters118US 7,598,412 B2Vertex Pharmaceuticals Incorporated · 2009
- Benzene compound having 2 or more substituents87US 7,923,573 B2Daiichi Sankyo Company, Limited · 2011
- Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof78US 7,476,399 B2Senomyx, Inc. · 2009
- Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation62US 6,653,340 B1BioCryst Pharmaceuticals, Inc. · 2003
- Prodrugs of CC-1065 analogs58US 6,756,397 B2ImmunoGen, Inc. · 2004